NCCTG Phase II Trial (N0621) of the SRC inhibitor AZD0530 after 4 cycles of cytoreductive chemotherapy for patients with Extensive Stage Small Cell Lung Cancer (ED-SCLC)
- Citation:
- J Thorac Oncol vol 4 (9) abstr PD4.3.4
- Meeting Instance:
- IASLC (WCLC) 2009
- Year:
- 2009
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 2170
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- Julian R. Molina Nathan R. Foster Garth D. Nelson Andrew V. Grainger Preston D. Steen Daniel A. Nikcevich Steven E. Schild John Wright Alex A. Adjei
- Networks:
- Study
- NCCTG-N0621
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: